Literature DB >> 8751906

Interleukin-12 regulation of host defenses against Coccidioides immitis.

D M Magee1, R A Cox.   

Abstract

We have previously reported on the alternate regulation of gamma interferon (IFN-gamma) and interleukin-4 (IL-4) in inbred mouse strains which differ in their susceptibility to Coccidioides immitis. The genetically resistant DBA/2 mice manifest a predominant T-helper 1 (Th1) response, with early production of IFN-gamma, whereas susceptible BALB/c mice show an early production of the Th2 cytokine IL-4. Since IL-12 is one cytokine that can act early during host defenses to promote the differentiation of cytokine production towards IFN-gamma and thus may promote expression of a protective immune response, we investigated the role of IL-12 in resistance to C. immitis. Administration of recombinant IL-12 to the susceptible mouse strain before and after systemic (intraperitoneal) challenge with C. immitis significantly ameliorated the course of the disease, as measured by a reduction in the fungal load in the lungs, liver, and spleen. Analysis of the cytokine mRNA in lungs from infected BALB/c mice revealed that the protective effect of recombinant IL-12 was accompanied by a shift from a Th2 to a Th1 response. The importance of IL-12 in resistance to this fungus was further established by showing that neutralization of endogenous IL-12 in the resistant DBA/2 mouse strain led to a significant increase in the fungal burden in pulmonary and extrapulmonary tissues. These results establish that IL-12 plays a pivotal role in the host defense against systemic challenge with C. immitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751906      PMCID: PMC174270          DOI: 10.1128/iai.64.9.3609-3613.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Interleukin-12 and its role in the generation of TH1 cells.

Authors:  G Trinchieri
Journal:  Immunol Today       Date:  1993-07

2.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.

Authors:  T M Scharton; P Scott
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

3.  Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.

Authors:  C A Hunter; C S Subauste; V H Van Cleave; J S Remington
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

4.  Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.

Authors:  R T Gazzinelli; M Wysocka; S Hayashi; E Y Denkers; S Hieny; P Caspar; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

5.  Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis.

Authors:  K V Clemons; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization.

Authors:  G Lack; H Renz; J Saloga; K L Bradley; J Loader; D Y Leung; G Larsen; E W Gelfand
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

7.  Effects of IL-12 on the response and susceptibility to experimental viral infections.

Authors:  J S Orange; S F Wolf; C A Biron
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

8.  Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis.

Authors:  L Romani; A Mencacci; L Tonnetti; R Spaccapelo; E Cenci; S Wolf; P Puccetti; F Bistoni
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

9.  Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma.

Authors:  C S Tripp; M K Gately; J Hakimi; P Ling; E R Unanue
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

10.  Interleukin-12 enhances murine survival against acute toxoplasmosis.

Authors:  I A Khan; T Matsuura; L H Kasper
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more
  36 in total

1.  Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.

Authors:  C Jiang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Endogenous interleukin-12 is not required for resolution of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection in mice.

Authors:  L Del Río; A J Buendía; J Sánchez; M C Gallego; M R Caro; N Ortega; J Seva; F J Pallarés; F Cuello; J Salinas
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses.

Authors:  C Y Hung; N M Ampel; L Christian; K R Seshan; G T Cole
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Inflammatory and Anti-inflammatory Responses Co-exist Inside Lung Granuloma of Fatal Cases of Coccidioidomycosis: A Pilot Report.

Authors:  Heidi G Rodriguez-Ramirez; Adolfo Soto-Dominguez; Gloria M González; Oralia Barboza-Quintana; Mario C Salinas-Carmona; Luis A Ceceñas-Falcon; Roberto Montes-de-Oca-Luna; Alma Y Arce-Mendoza; Adrian G Rosas-Taraco
Journal:  Mycopathologia       Date:  2018-05-07       Impact factor: 2.574

5.  Role of B cells in vaccine-induced immunity against coccidioidomycosis.

Authors:  D Mitchell Magee; Rhonda L Friedberg; Melanie D Woitaske; Stephen Albert Johnston; Rebecca A Cox
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 6.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

Review 7.  Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Authors:  K N Sorensen; K V Clemons; D A Stevens
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

8.  Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice.

Authors:  V Letscher-Bru; O Villard; B Risse; M Zauke; J P Klein; T T Kien
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 9.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis.

Authors:  J Fierer; L Walls; L Eckmann; T Yamamoto; T N Kirkland
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.